(VIANEWS) – ANI Pharmaceuticals (ANIP), Aon plc (AON), Lifeway Foods (LWAY) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ANI Pharmaceuticals (ANIP)
25.8% sales growth and 5.9% return on equity
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Earnings Per Share
As for profitability, ANI Pharmaceuticals has a trailing twelve months EPS of $1.19.
PE Ratio
ANI Pharmaceuticals has a trailing twelve months price to earnings ratio of 48.6. Meaning, the purchaser of the share is investing $48.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.9%.
2. Aon plc (AON)
24.2% sales growth and 82.44% return on equity
Aon plc, a professional services firm, provides a range of risk and human capital solutions worldwide. It offers commercial risk solutions, including retail brokerage, specialty solutions, global risk consulting and captives management, and affinity programs; and health solutions, such as health and benefits brokerages, and health care exchanges. The company also provides treaty and facultative reinsurance, as well as insurance-linked securities, capital raising, strategic advice, restructuring, and mergers and acquisitions services; and corporate finance advisory services. In addition, it offers strategic design consulting services on their retirement programs, actuarial services, and risk management services; and advice services on developing and maintaining investment programs across various plan types, including defined benefit plans, defined contribution plans, endowments, and foundations for public and private companies, and other institutions. Aon plc was founded in 1919 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, Aon plc has a trailing twelve months EPS of $12.5.
PE Ratio
Aon plc has a trailing twelve months price to earnings ratio of 24.64. Meaning, the purchaser of the share is investing $24.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 82.44%.
3. Lifeway Foods (LWAY)
22.9% sales growth and 22.62% return on equity
Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream. It sells its products under the Lifeway, Glen Oaks Farms, and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was incorporated in 1986 and is based in Morton Grove, Illinois.
Earnings Per Share
As for profitability, Lifeway Foods has a trailing twelve months EPS of $0.9.
PE Ratio
Lifeway Foods has a trailing twelve months price to earnings ratio of 29.33. Meaning, the purchaser of the share is investing $29.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.62%.
4. Shopify (SHOP)
21.6% sales growth and 15.31% return on equity
Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, Australia, China, and Latin America. The company's platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. It also sells custom themes and apps, and registration of domain names; and merchant solutions, which include accepting payments, shipping, and securing working capital. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.
Earnings Per Share
As for profitability, Shopify has a trailing twelve months EPS of $0.1.
PE Ratio
Shopify has a trailing twelve months price to earnings ratio of 700. Meaning, the purchaser of the share is investing $700 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.31%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 12.5% and 8.7%, respectively.
Yearly Top and Bottom Value
Shopify’s stock is valued at $70.00 at 11:22 EST, way under its 52-week high of $91.57 and way higher than its 52-week low of $45.50.
Previous days news about Shopify(SHOP)
- The zacks analyst blog JPMorgan, medtronic, Shopify and perma-pipe international. According to Zacks on Wednesday, 9 October, "All these factors support our bullish stance on the stock.(You can read the full research report on Medtronic here >>>)Shares of Shopify have gained +3.8% over the year-to-date period against the Zacks Internet – Services industry’s gain of +15.7%. ", "Today’s Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co., Medtronic plc and Shopify Inc., as well as a micro-cap stock Perma-Pipe International Holdings, Inc. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country."
- 3 reasons Shopify stock is a buy: beyond the 21% surge in a month. According to Zacks on Wednesday, 9 October, "Its partnership with Amazon allows Shopify merchants to use the former’s massive fulfillment network. ", "Alphabet division YouTube recently expanded its partnership with Shopify to bring more brands for its YouTube Shopping affiliate program."
- According to Zacks on Wednesday, 9 October, "Some other top-ranked stocks in the broader sector are Shopify (SHOP Quick QuoteSHOP – Free Report) , Gitlab (GTLB Quick QuoteGTLB – Free Report) , and Bentley Systems (BSY Quick QuoteBSY – Free Report) , each sporting a Zacks Rank #1(Strong Buy) at present. "
5. Medpace Holdings (MEDP)
11.1% sales growth and 58.85% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $10.64.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 30.13. Meaning, the purchaser of the share is investing $30.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 58.85%.
Moving Average
Medpace Holdings’s value is way below its 50-day moving average of $373.78 and way under its 200-day moving average of $371.18.
Sales Growth
Medpace Holdings’s sales growth is 10.2% for the ongoing quarter and 11.1% for the next.
6. Saia (SAIA)
7.3% sales growth and 19.61% return on equity
Saia, Inc., through its subsidiaries, operates as a transportation company in North America. The company provides less-than-truckload services for shipments between 400 and 10,000 pounds; and other value-added services, including non-asset truckload, expedited, and logistics services. As of December 31, 2021, it operated 176 owned and leased facilities; and owned approximately 5,600 tractors and 19,300 trailers. The company was formerly known as SCS Transportation, Inc. and changed its name to Saia, Inc. in July 2006. Saia, Inc. was founded in 1924 and is headquartered in Johns Creek, Georgia.
Earnings Per Share
As for profitability, Saia has a trailing twelve months EPS of $14.21.
PE Ratio
Saia has a trailing twelve months price to earnings ratio of 30.74. Meaning, the purchaser of the share is investing $30.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.61%.
Moving Average
Saia’s worth is higher than its 50-day moving average of $408.02 and under its 200-day moving average of $468.31.
Sales Growth
Saia’s sales growth is 8.4% for the present quarter and 7.3% for the next.
7. Hyster (HY)
5.8% sales growth and 45.11% return on equity
Hyster-Yale Materials Handling, Inc., through its subsidiaries, designs, engineers, manufactures, sells, and services a line of lift trucks, attachments, and aftermarket parts worldwide. It manufactures components, such as frames, masts, and transmissions; and assembles lift trucks. The company markets its products primarily under the Hyster and Yale brand names to independent Hyster and Yale retail dealerships. It also sells aftermarket parts under the Hyster and Yale, as well as UNISOURCE and PREMIER brands to Hyster and Yale dealers for the service of competitor lift trucks. In addition, the company produces and distributes attachments, forks, and lift tables under the Bolzoni, Auramo, and Meyer brand names; and designs and produces products in the port equipment and rough terrain forklift markets. Further, it designs, manufactures, and sells hydrogen fuel-cell stacks and engines. The company serves light and heavy manufacturers, trucking and automotive companies, rental companies, building materials and paper suppliers, lumber, metal products, warehouses, retailers, food distributors, container handling companies, and U.S. and non-U.S. governmental agencies. Hyster-Yale Materials Handling, Inc. was incorporated in 1991 and is headquartered in Cleveland, Ohio.
Earnings Per Share
As for profitability, Hyster has a trailing twelve months EPS of $9.99.
PE Ratio
Hyster has a trailing twelve months price to earnings ratio of 6.38. Meaning, the purchaser of the share is investing $6.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.11%.
Yearly Top and Bottom Value
Hyster’s stock is valued at $63.77 at 11:22 EST, way under its 52-week high of $84.44 and way higher than its 52-week low of $38.50.
Moving Average
Hyster’s value is under its 50-day moving average of $64.17 and under its 200-day moving average of $65.51.
Sales Growth
Hyster’s sales growth for the next quarter is 5.8%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 30, 2024, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 2.2%.
